Formycin A

Drug Profile

Formycin A

Latest Information Update: 17 Jul 2001

Price : $50

At a glance

  • Originator Unknown
  • Developer Nonindustrial source
  • Class Antibacterials; Antihyperglycaemics; Antineoplastics; Pyrimidines
  • Mechanism of Action Gastric inhibitory polypeptide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Type 2 diabetes mellitus

Most Recent Events

  • 17 Jul 2001 No-Development-Reported for Type-2 diabetes mellitus in Belgium (Unknown route)
  • 04 Aug 1995 An in vitro study has been added to the pharmacodynamics section
  • 04 Aug 1995 Preclinical development for Type-2 diabetes mellitus in Belgium (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top